Serendipity points to new potential target and therapy for melanoma
(Medical Xpress)—A University of Colorado Cancer Center study in this month's edition of the Journal of Investigative Dermatology describes a new target and potential treatment for melanoma, the most d ...
Cancer
Dec 20, 2012 |
not rated yet |
0
|
Game changing diagnostic and prognostic prostate cancer genetic tests revealed
Researchers at the Kimmel Cancer Center at Jefferson (KCC) have developed potentially game-changing diagnostic and prognostic genetic tests shown to better predict prostate cancer survival outcomes and distinguish clinically-relevant ...
Cancer
Dec 20, 2012 |
not rated yet |
0
Surviving sepsis with LECT2
Failure to launch an adequate immune response may be at the root of septic shock, according to a study published in The Journal of Experimental Medicine on December 17th.
Medical research
Dec 17, 2012 |
not rated yet |
0
Study finds new targets for drugs to defeat aggressive brain tumor
University of Pittsburgh Cancer Institute (UPCI) researchers have identified over 125 genetic components in a chemotherapy-resistant, brain tumor-derived cell line, which could offer new hope for drug treatment to destroy ...
Cancer
Dec 14, 2012 |
not rated yet |
0
|
MicroRNA-218 targets medulloblastoma, most aggressive childhood brain cancer
Between the blueprint of the genome and the products of its expression lie microRNAs, which can boost or lower the rate at which genes become stuff. In fact, many cancers use microRNA to magnify the expression of faulty genes ...
Cancer
Dec 13, 2012 |
5 / 5 (1) |
0
|
Scientists identify new biomarker for cancer in bone marrow: Promise for patients of multiple myeloma
Singapore scientists have identified FAIM, a molecule that typically prevents cell death, as a potential biomarker to identify an incurable form of cancer in the bone marrow. Patients with this form of cancer usually do not ...
Cancer
Dec 13, 2012 |
not rated yet |
0
Experimental graft-vs.-host disease treatment equivalent to standard care in Phase 3 trial
An experimental drug combination for preventing graft-versus-host disease (GVHD) was not significantly better than the standard regimen on key endpoints, according to a report of a phase 3 trial at the American Society of ...
Cancer
Dec 10, 2012 |
not rated yet |
0
Another muscular dystrophy mystery solved; MU scientists inch closer to a therapy for patients
Approximately 250,000 people in the United States suffer from muscular dystrophy, which occurs when damaged muscle tissue is replaced with fibrous, bony or fatty tissue and loses function. Three years ago, University of Missouri ...
Medical research
Dec 07, 2012 |
4.5 / 5 (2) |
0
|
Nanotechnology drug delivery shows promise for treatment of pediatric cancer
This month, Molecular Pharmaceutics reported promising findings from the Nemours Center for Childhood Cancer Research and the Materials Science and Engineering Department at the University of Delaware, about the potential for na ...
Cancer
Dec 04, 2012 |
not rated yet |
0
Clinical trial targets advanced prostate cancer
Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.
Cancer
Dec 03, 2012 |
5 / 5 (1) |
0
New hope for setback-dogged cancer treatment
Several drugs companies have ineffectively tried to produce antibodies that bind to the IGF-1 receptor on the cell surface, which has a critical part to play in the development of cancer. Scientists at Karolinska Institutet ...
Cancer
Nov 26, 2012 |
4.8 / 5 (4) |
1
|
From degeneration to regeneration: Advances in skeletal muscle engineering
A study published today in BioMed Central's open access journal Skeletal Muscle reports of a new therapeutic technique to repair and rebuild muscle for sufferers of degenerative muscle disorders. The therapy brings togeth ...
Medical research
Nov 26, 2012 |
5 / 5 (1) |
0
Nephron sparing surgery has excellent lasting outcomes
(HealthDay)—For patients with bilateral renal masses, nephron sparing surgery (NSS) results in excellent long-term oncological and functional outcomes and survival rates, according to a study published ...
Surgery
Nov 19, 2012 |
not rated yet |
0
Black patients with kidney cancer have poorer survival than whites
Among patients with the most common form of kidney cancer, whites consistently have a survival advantage over blacks, regardless of patient and tumor characteristics or surgical treatment. That is the conclusion of a new ...
Cancer
Nov 12, 2012 |
not rated yet |
0
Novel cell growth factor for preventing and treating injury caused by high-level radiation exposure
Japanese researchers have created novel cell growth factor FGFC that is considered effective in preventing and treating injury due to high-dose radiation. Until now, there have been insufficient drugs effective ...
Medical research
Nov 02, 2012 |
5 / 5 (1) |
0
